Could Benitec Biopharma Limited – American Depositary SH (NASDAQ:BNTC) Change Direction After Less Shorts?

May 18, 2018 - By wolcottdaily

Benitec Biopharma Limited (NASDAQ:BNTC) Logo

The stock of Benitec Biopharma Limited – American Depositary SH (NASDAQ:BNTC) registered a decrease of 14.08% in short interest. BNTC’s total short interest was 65,900 shares in May as published by FINRA. Its down 14.08% from 76,700 shares, reported previously. With 8,800 shares average volume, it will take short sellers 8 days to cover their BNTC’s short positions. The short interest to Benitec Biopharma Limited – American Depositary SH’s float is 1.06%.

The stock decreased 3.45% or $0.09 during the last trading session, reaching $2.52. About 17,764 shares traded or 42.19% up from the average. Benitec Biopharma Limited (NASDAQ:BNTC) has risen 22.31% since May 18, 2017 and is uptrending. It has outperformed by 10.76% the S&P500.

Benitec Biopharma Limited, a biotechnology company, develops treatments for chronic and life-threatening human diseases based on its gene silencing therapy, DNA-directed RNA interference in Australia and the United States. The company has market cap of $27.18 million. The firm provides BB-301, a single administration ddRNAi gene therapy for the treatment of oculopharyngeal muscular dystrophy; BB-201, a ddRNAi therapy for the treatment of wet age-related macular degeneration; and BB-101 and BB-103 ddRNAi therapies for the treatment of human hepatitis B. It currently has negative earnings. It also offers BB-401 and BB-501 for the treatment of oncology.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.